Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2013, Article ID 157857, 13 pages
http://dx.doi.org/10.1155/2013/157857
Research Article

NADPH Oxidase and the Degeneration of Dopaminergic Neurons in Parkinsonian Mice

Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of São Paulo, São Paulo, 05508-900 SP, Brazil

Received 9 August 2013; Revised 8 October 2013; Accepted 23 October 2013

Academic Editor: Tiago Fleming Outeiro

Copyright © 2013 Marina S. Hernandes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [22 citations]

The following is the list of published articles that have cited the current article.

  • Kyle Farmer, Catherine A. Smith, Shawn Hayley, and Jeffrey Smith, “Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson's Disease,” International Journal Of Molecular Sciences, vol. 16, no. 8, pp. 18865–18877, 2015. View at Publisher · View at Google Scholar
  • Catherine A. Smith, Jeffrey Smith, Kyle Farmer, and Shawn Hayley, “Major alterations of phosphatidylcholine and lysophosphotidylcholine lipids in the substantia nigra using an early stage model of parkinson’s disease,” International Journal of Molecular Sciences, vol. 16, no. 8, pp. 18865–18877, 2015. View at Publisher · View at Google Scholar
  • Sandeep Vasant More, and Dong-Kug Choi, “Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection,” Molecular Neurodegeneration, vol. 10, no. 1, 2015. View at Publisher · View at Google Scholar
  • Yu-Min Wang, Yue-Hua Wang, Guan-Hua Du, and Hong-Quan Wang, “Research progress of targeting HO-1/NOX2 pathway for the treatment of Parkinson's disease,” Chinese Pharmaceutical Journal, vol. 50, no. 23, pp. 2024–2027, 2015. View at Publisher · View at Google Scholar
  • Julien Cachat, Christine Deffert, Stephanie Hugues, and Karl-Heinz Krause, “Phagocyte NADPH oxidase and specific immunity,” Clinical Science, vol. 128, no. 10, pp. 635–648, 2015. View at Publisher · View at Google Scholar
  • G J McBean, M G López, and F K Wallner, “Redox-based therapeutics in neurodegenerative disease,” British Journal of Pharmacology, 2016. View at Publisher · View at Google Scholar
  • Anantha Harijith, Viswanathan Natarajan, Alison W. Ha, Panfeng Fu, Yue-Ting Wang, Prasad Kanteti, Srikanth Pendyala, David L. Ebenezer, Ke Ma, Peter T. Toth, and Evgeny V. Berdyshev, “Hyperoxia-induced p47phox activation and ROS generation is mediated through S1P transporter Spns2, and S1P/S1P1&2 signaling axis in lung endothelium,” American Journal of Physiology - Lung Cellular and Molecular Physiology, vol. 311, no. 2, pp. L337–L351, 2016. View at Publisher · View at Google Scholar
  • Pichaya Jumnongprakhon, Piyarat Govitrapong, Chainarong Tocharus, and Jiraporn Tocharus, “Inhibitory effect of melatonin on cerebral endothelial cells dysfunction induced by methamphetamine via NADPH oxidase-2,” Brain Research, 2016. View at Publisher · View at Google Scholar
  • Tianfang Jiang, Qian Sun, and Shengdi Chen, “Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease,” Progress in Neurobiology, 2016. View at Publisher · View at Google Scholar
  • Mariana Babayeva, Haregewein Assefa, Paramita Basu, Sanjeda Chumki, and Zvi Loewy, “Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy,” Parkinson's Disease, vol. 2016, pp. 1–19, 2016. View at Publisher · View at Google Scholar
  • Kim Wieczorek Austin, Suzanne Weil Ameringer, and Leslie Jameleh Cloud, “An Integrated Review of Psychological Stress in Parkinson’s Disease: Biological Mechanisms and Symptom and Health Outcomes,” Parkinson's Disease, vol. 2016, pp. 1–15, 2016. View at Publisher · View at Google Scholar
  • Mohsen Hemmati-Dinarvand, Ali-Akbar Taher-Aghdam, Ali Mota, Sepideh Zununi Vahed, and Nasser Samadi, “Dysregulation of serum NADPH oxidase1 and ferritin levels provides insights into diagnosis of Parkinson's disease,” Clinical Biochemistry, 2017. View at Publisher · View at Google Scholar
  • Katherine Garcia Ravelli, Barbara dos Anjos Rosário, Andrea Rodrigues Vasconcelos, Cristoforo Scavone, Rosana Camarini, Marina Sorrentino Hernandes, and Luiz Roberto Britto, “NADPH oxidase contributes to streptozotocin-induced neurodegeneration,” Neuroscience, 2017. View at Publisher · View at Google Scholar
  • Marcela L. Contreras, Erwin de la Fuente-Ortega, Sof?a Vargas-Roberts, Daniela C. Mu?oz, Carolina A. Goic, and Paola A. Haeger, “NADPH Oxidase Isoform 2 (NOX2) Is Involved in Drug Addiction Vulnerability in Progeny Developmentally Exposed to Ethanol,” Frontiers in Neuroscience, vol. 11, 2017. View at Publisher · View at Google Scholar
  • Gyun Jee Song, and Kyoungho Suk, “Pharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative Diseases,” Frontiers in Aging Neuroscience, vol. 9, 2017. View at Publisher · View at Google Scholar
  • Jung-Hoon Koo, Yong-Chul Jang, Dong-Ju Hwang, Hyun-Seob Um, Nam-Hee Lee, Jae-Hoon Jung, and Joon-Yong Cho, “Treadmill exercise produces neuroprotective effects in a murine model of Parkinson’s disease by regulating the TLR2/MyD88/NF-κB signaling pathway,” Neuroscience, 2017. View at Publisher · View at Google Scholar
  • Karim Belarbi, Elodie Cuvelier, Alain Destée, Bernard Gressier, and Marie-Christine Chartier-Harlin, “NADPH oxidases in Parkinson’s disease: a systematic review,” Molecular Neurodegeneration, vol. 12, no. 1, 2017. View at Publisher · View at Google Scholar
  • Merry W. Ma, Jing Wang, Quanguang Zhang, Ruimin Wang, Krishnan M. Dhandapani, Ratna K. Vadlamudi, and Darrell W. Brann, “NADPH oxidase in brain injury and neurodegenerative disorders,” Molecular Neurodegeneration, vol. 12, no. 1, 2017. View at Publisher · View at Google Scholar
  • Michael Fricker, Aviva M. Tolkovsky, Vilmante Borutaite, Michael Coleman, and Guy C. Brown, “Neuronal Cell Death,” Physiological Reviews, vol. 98, no. 2, pp. 813–880, 2018. View at Publisher · View at Google Scholar
  • Vivek Kumar Garg, Seema Gupta, Soma Dey, Shivani Jaswal, and Jasbinder Kaur, “How can NOX1 and ferritin be used as diagnostic and prognostic biomarkers in Parkinson's disease?,” Clinical Biochemistry, 2018. View at Publisher · View at Google Scholar
  • Hwei-Hsien Chen, Pei-Chi Chang, Shiaw-Pyng Wey, Pei-Mei Chen, Chinpiao Chen, and Ming-Huan Chan, “Therapeutic effects of honokiol on motor impairment in hemiparkinsonian mice are associated with reversing neurodegeneration and targeting PPARγ regulation,” Biomedicine & Pharmacotherapy, vol. 108, pp. 254–262, 2018. View at Publisher · View at Google Scholar
  • Mavis A A Tenkorang, Phong Duong, and Rebecca L Cunningham, “NADPH Oxidase Mediates Membrane Androgen Receptor–Induced Neurodegeneration,” Endocrinology, vol. 160, no. 4, pp. 947–963, 2019. View at Publisher · View at Google Scholar